Tiny metal particles show potential in targeting cancer cells: Study
New Delhi, Oct 24
Researchers have developed microscopic metal particles that can kill cancer cells while sparing healthy tissue, offering a potential new direction for more targeted and less toxic cancer treatments.
The study by the team from the Royal Melbourne Institute of Technology (RMIT) in Australia remains at the cell-culture stage and has not been tested in animals or humans, Xinhua news agency reported.
However, it suggests a new strategy for designing cancer treatments that exploits cancer's own weaknesses.
The international team led by RMIT researchers created tiny particles, known as nanodots, from molybdenum oxide -- a compound based on a rare metal called molybdenum. It is often used in electronics and alloys.
By tweaking their chemical composition, the scientists enabled the particles to release reactive oxygen molecules -- unstable forms of oxygen that damage cancer cells and trigger their self-destruction.
In tests, the particles killed three times more cervical cancer cells than healthy cells within 24 hours, without the need for light, unusual for technologies that rely on oxidative stress, according to the study published in the journal Advanced Science.
"Cancer cells already live under higher stress than healthy ones. Our particles push that stress a little further, enough to trigger self-destruction in cancer cells, while healthy cells cope just fine," said Zhang Baoyue, first author from the RMIT School of Engineering.
"The result was particles that generate oxidative stress selectively in cancer cells under lab conditions," Zhang said.
Most cancer treatments affect both cancerous and healthy tissue, but technologies that selectively stress cancer cells could enable gentler, more targeted therapies, researchers said.
They added that these particles are made from common metal oxide instead of costly or toxic noble metals like gold or silver, making them likely cheaper and safer to develop.
— IANS
Reader Comments
Great to see research focusing on targeted therapy. Current cancer treatments in India often cause so much collateral damage to healthy cells. If this works, it could revolutionize cancer care in our country where healthcare costs are a major concern.
While the research sounds promising, let's not get too excited yet. It's still in cell-culture stage and hasn't been tested on animals or humans. Many such breakthroughs fail in later stages. We need more Indian research institutions working on similar innovations.
The concept of using cancer's own weaknesses against it is brilliant! Hope this technology gets fast-tracked for further testing. Cancer rates are rising in urban India, and we desperately need better treatment options.
Using molybdenum oxide instead of expensive noble metals is a smart move. This could make cancer treatment more affordable for middle-class families in India who often struggle with medical expenses. Hope our AIIMS and other research centers collaborate on such projects.
The selective oxidative stress approach is fascinating. It's like giving cancer cells just enough extra pressure to break them, while healthy cells can handle it. Hope this research gets the funding it needs to progress to human trials. 🤞
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.